Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning - a Multicenter Interrupted Time Series Study (INVERT Study)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6,525
- 试验地点
- 1
- 主要终点
- Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) (Yes/no)
研究概览
简要总结
To assess the impact of an e-learning course in neuromuscular monitoring on the frequency of application of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia and secondarily on the incidence of residual neuromuscular blockade after anesthesia.
We will collect data prospectively from 6 Danish anaesthesia departments from the time of intervention, using data from the Anaesthesia Information Management System (AIMS). Baseline data is obtained from another study based on the same data extraction procedure (NCT02914119).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) (Yes/no)
时间窗: in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours
Number of Participants Who Received a Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine) and was Monitored with Objective Neuromuscular Monitoring (Acceleromyography). Data on neuromuscular monitoring is automatically registered in the electronic patient chart when the equipment for acceleromyography is activated.
Application of Objective Neuromuscular Monitoring (Acceleromyography) in Cases Receiving a Non-depolarizing NMBA (Yes/no)
时间窗: in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours
Number of Participants Who Received a Non-depolarizing Neuromuscular Blocking Agent (NMBA) and was Monitored with Objective Neuromuscular Monitoring (Acceleromyography). Data on neuromuscular monitoring is automatically registered in the electronic patient chart when the equipment for acceleromyography is activated.
次要结局
- Time in Minutes From Tracheal Extubation or Removal of Supraglottic Airway Device to Discharge From Post-anaesthesia Care Unit in Cases Involving a Non-depolarizing NMBA(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 180 minutes)
- Administration of Neostigmine in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)
- Administration of More Than One Reversal Agent in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)
- Last Recorded Train-of-four (TOF) Ratio Before Tracheal Extubation or Removal of Supraglottic Airway Device in Patients Receiving a Non-depolarizing NMBA(in the period from induction of anaesthesia to termination of anaesthesia, usually 2 hours])
- Administration of Sugammadex in Cases Receiving a Non-depolarizing NMBA (Yes/no)(in the period from induction of anaesthesia to discharge from the post-anaesthesia care unit, usually 5 hours)